Trial intelligence / Profile preview

APEX Trial: Allopurinol in Cardiac Syndrome X

2007-002293-54Phase 4Completed

Sponsor
University of Dundee
Start
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of allopurinol in Coronary Small Vessel Disease (CMD), sponsored by University of Dundee. Primary endpoint: Coronary microvascular function. Started Oct 2007; status: completed.

02

Drugs

allopurinol
03

Conditions

Coronary Small Vessel Disease (CMD)

Beyond the preview

Go deeper on 2007-002293-54.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002293-54.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call